The Priorix Vaccine is a live, attenuated vaccine designed for active immunization against measles, mumps, and rubella. This vaccine is suitable for individuals aged 12 months and older. It is supplied as a single-dose vial of lyophilized antigen component to be reconstituted with a prefilled syringe of sterile water diluent component.
Key FeaturesUsed for the prevention of measles, mumps, and rubella in children and adults.
Typical User/Industry ProfileHealthcare providers, pediatricians, and clinics offering immunization services.
About the BrandPriorix is manufactured by GlaxoSmithKline, a leader in vaccine development and production. The company is renowned for its commitment to public health and innovation in vaccine technology.